Pharmaceuticals in 2025Market New Landscape

It is estimated that the global pharmaceutical equipment market will exceed $98 billion in 2025,with China’s share of imported equipment remaining stable at 32%-35%.In the field of biopharmaceutical equipment,the latest data from the German B+S Group shows that the tariff reduction policy for imported sterilization equipment and freeze-dryers in China will be extended to 2025.11 tariff codes,which places higher demands on agencies policy interpretation capabilities.

Three core battlefields in the import process

First battlefield: Pre-approval of access qualifications

• EquivalencedeterminationbetweenEUCEcertificationandFDA510(k)
  • VerifywhethertheequipmentbelongstoCategoryIIcontrolintheClassificationCatalog
  • BioreactorimportsrequiresimultaneoussubmissionofGMPenvironmentvalidationdocuments
• Technical parameter difference compensation mechanism
• Cost calculation for voltage frequency conversion (50Hz/60Hz)
• Error between equipment nameplate and customs declaration data must be controlled within ±3%

Second battlefield: Precise application of tariff preferences

• Strategiesforimprovingutilizationoffreetradeagreements
  • TariffreductionforJapanese-madecentrifugesunderRCEPfrom5%to3.8%
  • Duty-freeclauseforcorecomponentsoffreezedryersunderChina-SwitzerlandFTA
• Typical cases of classification disputes
• A German-imported chromatography system caused 376,000 yuan in tax losses due to HS code misdeclaration

Five screening dimensions for agency service providers

When comparing procurement cases of a foreign-funded pharmaceutical company in Shanghai,it was found that professional agency companies could save customers14.7%comprehensive costs:

• WhetherthecustomsteampossessesAEOAdvancedCertificationservicequalifications
• Overseaspre-inspectionservicescoverEUGMPauditstandards
• Emergencyresponsecapability(completingtariffclassificationreconsiderationwithin48hours)
• Complianceassurancemechanismfortechnicaldocumenttranslation
• Localizedcustomsclearancenetworkcoveringmajorpharmaceuticalinspectionports

Construction logic of risk prevention and control system

Typical problems encountered by a listed company when importing sterilization cabinets:

• Technicalspecificationsdidnotindicatemaximumworkingpressureparameters
• Delayeddeclarationofpressurevesselregulatorydocumentsby23workingdays
• Finallyresolvedthroughtheagencycompanyssecondarydeclarationprocedureriskmitigation

Three-level early warning mechanism that professional agency services should include:

• Documentpre-reviewcompleted72hoursbeforeequipmentshipment
• Tripartiteverificationofdeclarationdataandtestreports
• Technicaltrademeasuresdynamictrackingsystem

2025 Industry Trend Response Strategy

According to the latest amendment of the "Tax Reduction and Exemption Management Measures" issued by the General Administration of Customs,special attention should be paid to the import of pharmaceutical equipment in 2025:

• Thevalidityperiodofencouragementcategoryprojectconfirmationlettershasbeenshortenedto6months
• Importedusedequipmentrequiresoriginalmanufacturersservicelifecertification
• BiosafetyLevel3laboratoryequipmentimplementsawhitelistmanagementsystem